TIGIT and neoplasm: With the deepening research on the immunosuppressive receptors on T cells, many studies have confirmed that the immunosuppressive receptor TIGIT expressed on the cell membranes of T cells and NK cells can bind to the ligand on the tumor-specific target cells to inhibit the function of the immune system (18, 20, 21).